Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: Increased specificity by using vascular maps

European Radiology

Volumn 18, Issue 2, 2008, Pages 355-364

  Schmitz, A C ^a   Peters, N H G M ^a   Veldhuis, W B ^a   Fernandez Gallardo, A M ^a   van Diest, P J ^a   Stapper, G ^a   van Hillegersberg, R ^a   Mali, W P Th M ^a   van den Bosch, M A A J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b STANFORD UNIVERSITY   (United States)

Author keywords

3.0 Tesla; Breast; Breast cancer; Gadobutrol; Magnetic resonance imaging

Indexed keywords

GADOBUTROL;

ADULT; ARTICLE; BREAST LESION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETICS; MIDDLE AGED; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 39049083828     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-007-0766-z     Document Type: Article

References (31)

1. Orel SG, Schnall MD, LiVolsi VA, Troupin RH (1994) Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 190:485-493
2. Sardanelli F, Iozzelli A, Fausto A (2003) MR imaging of the breast: indications, established technique and new directions. Eur Radiol 13 (Suppl 3):N28-N36
3. Sardanelli F, Podo F (2007) Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17:873-887
4. Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK (2003) MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180:901-910
5. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888
6. Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889-895
7. American College of Radiology (ACR) (2003) Breast imaging reporting and data system. Atlas BI-RADS. American College of Radiology, Reston, Va
8. Daniel BL, Yen YF, Glover GH, Ikeda DM, Birdwell RL, Sawyer-Glover AM, Black JW, Plevritis SK, Jeffrey SS, Herfkens RJ (1998) Breast disease: Dynamic spiral MR imaging. Radiology 209:499-509
9. Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV (1993) MR imaging of the breast with rotating delivery of excitation off resonance: Clinical experience with pathologic correlation. Radiology 187:493-501
10. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, Holland R, Ruys SH (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777-781
11. Stomper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, Blumenson LE (1995) Suspect breast lesions: Findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 197:387-395
12. Bone B, Aspelin P, Bronge L, Isberg B, Perbeck L, Veress B (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208-213
13. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, van Kaick G (1999) Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 10:260-266
14. Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, Schnall MD (2007) MRI Evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303
15. Mahfouz AE, Sherif H, Saad A, Taupitz M, Filimonow S, Kivelitz D, Hamm B (2001) Gadolinium-enhanced MR angiography of the breast: Is breast cancer associated with ipsilateral higher vascularity? Eur Radiol 11:965-969
16. Wright H, Listinsky J, Quinn C, Rim A, Crowe J, Kim J (2005) Increased ipsilateral whole breast vascularity as measured by contrast-enhanced magnetic resonance imaging in patients with breast cancer. Am J Surg 190:576-579
17. Sardanelli F, Iozzelli A, Fausto A, Carriero A, Kirchin MA (2005) Gadobenate dimeglumine-enhanced MR Imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology 235:791-797
18. Carriero A, Di Credico A, mansour M, Bonomo L (2002) Maximum intensity projection analysis in magnetic resonance of the breast. J Exp Clin Cancer Res 21(3 Suppl):77-81
19. Hylton NM (2001) Vascularity assessment of breast lesions with gadolinium-enhanced MR Imaging. Magn Reson Imaging Clin N Am 9:321-332
20. Nunes LW, Schnall MD, Orel SG, Hochman MG, Langlotz CP, Reynolds CA, Torosian MH (1997) Breast MR imaging: Interpretation model. Radiology 202:833-841
21. Hauth EA, Jaeger H, Maderwalld S, Stockamp C, Mühler A, Kimmig R, Forsting M (2006) Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography. Eur Radiol 16:2934-2941
22. Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM (2000) Dynamic high-spatial resolution MR imaging of suspicious breast lesions: Diagnostic criteria and interobserver variability. AJR Am J Roentgenol 175:35-43
23. Helbich TH (2000) Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 34:208-219
24. Pediconi F, Catalano C, Occhiato R, Venditti F, Fraioli F, Napoli A, Kirchin MA, Passariello R (2005) Breast lesion detection and characterization at contrast-enhanced MR mammography: Gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology 237:45-56
25. Hata T, Takahashi H, Watanabe K, Takahashi M, Taguchi K, Itoh T, Todo S (2004) Magnetic resonance imaging for preoperative evaluation of breast cancer: A comparative study with mammography and ultrasonography. J Am Coll Surg 198:190-197
26. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM (2004) Detection of breast malignancy: Diagnostic MR protocol for improved specificity. Radiology 232:585-591
27. Macura KJ, Ouwerkerk R, Jacobs MA, Bluemke DA (2006) Patterns of enhancement on breast MR images: Interpretation and imaging pitfalls. Radiographics 26:1719-1734
28. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild HH, Gieseke J (2006) Contrast-enhanced MR imaging of the breast at 3.0 and 1.5T in the same patients: Initial experience. Radiology 239:666-676
29. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F (2006) Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 41:213-221
30. Goyen M, Herborn CU, Vogt FM, Kroger K, Verhagen R, Yang F, Bosk S, Bebatin JF, Ruehm SG (2003) Using a 1 M Gd-chelate (gadobutrol) for totalbody three-dimensional MR angiography: Preliminary experience. J Magn Reson Imaging 17:565-571
31. Tombach B, Heindel W (2002) Value of 1.0-M gadolinium chelates: Review of preclinical and clinical data on gadobutrol. Eur Radiol 12:1550-1556